| (USD) | Dec 2023 | Q/Q |
|---|---|---|
| Revenue | 5.7MM | -57% |
| Gross Profit | 532K | -88% |
| Cost Of Revenue | 5.2MM | -40% |
| Operating Income | -12.7MM | - |
| Operating Expenses | 13.3MM | +88% |
| Net Income | -14.7MM | - |
| G&A | 5.6MM | -21% |
| Amortization | 340K | -11% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- Better Choice Company Inc. (NYSE American: BTTR) (the “Company” or “Better Choice”), a pet health and wellness company, announces that its Board of Directors has authorized a stock repurchase program under which the Company can repurchase up to $5 million of the currently outstanding shares of the Company’s common stock, until December 31, 2024. Shares may be repurchased in open market or private transactions or pursuant to any trading plan that may b
Gross Margin Improved 300 basis points to 31% Year-Over-Year Adjusted EBITDA Grew 30% Year-Over-Year EPS Grew 45% Year-Over-Year TAMPA, Fla., April 12, 2024 (GLOBE NEWSWIRE) -- Better Choice Company Inc. (NYSE American: BTTR) (the “Company” or “Better Choice”), a pet health and wellness company, today reported its financial results for the fourth quarter and year ended December 31, 2023. Kent Cunningham, CEO of Better Choice, stated, “In 2023, we realized significant gross margin improvement to
NEW YORK, March 26, 2024 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, initiated a legal action to enforce a right of first refusal (“ROFR”) option exercised by Alphia, Inc. (“Alphia”) BL4424547, which is controlled by a Paris-based private equity firm, PAI Partners (https://www.paipartners.com). Pursuant to the terms of a written agreement between Alphia and the Company, Alphia is obligated to acquire the asse
TAMPA, Fla., March 08, 2024 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, announced today that it will proceed with a 1-for-44 reverse stock split (the “Reverse Split”) of its issued and outstanding shares of common stock, par value $0.001, following authorization by its Board of Directors and majority shareholders to effect a reverse stock split by a ratio of not less than 1-for-25 and not more than 1
NEW YORK, March 04, 2024 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or “the Company”), a pet health and wellness company, today announced that after successfully completing the acquisition of Aimia, the Company will explore and evaluate proposals to monetize and fund ownership in its R&D platform with the goal to bring in partners to participate in the evolution of a treat-based GLP1 supplement to combat obesity in dogs and cats. About Better Choice Company, Inc.Bett
NEW YORK, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or “the Company”), a pet health and wellness company, today announced the acquisition of all the issued and outstanding common shares of Aimia Pet Healthco Inc. (‘Aimia’). Better Choice will now be in a position to manage the clinical trials internally in hopes to develop a supplement to support weight loss in domestic animals. More than half of all dogs and cats worldwide are classified as overweight
TAMPA, Fla., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, today announced its research partner, Aimia Pet HealthCo. Inc. (APH), has signed a memorandum of understanding (MOU) with KGK Science Inc. (KGK) for the development of a GLP1 supplement for pets. The MOU sets out the basis for KGK to commence research and development of a GLP1 supplement for use in companion animals. Combining a GLP1 supplement
Third Quarter 2023 Revenue Grew 11% Year-Over-Year to $13.1 millionAdjusted EBITDA Growth of 95% Year-Over-Year EPS Growth of 77% Year-Over-Year TAMPA, FLORIDA, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (“Better Choice” or the “Company”) (NYSE American: BTTR), a pet health and wellness company, today announced its results for the third quarter ended September 30, 2023 (“Q3 2023”). THIRD QUARTER 2023 FINANCIAL HIGHLIGHTS Revenue increased 24% from second quarter 2023, and 11%
TAMPA, Fla., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, and its research partner, Aimia Pet HealthCo Inc. (APH), today announced that APH has signed a memorandum of understanding (MOU) with Dr. Nadia Crosignani for the development of a GLP1 supplement for pets. The MOU sets out the basis for Dr. Crosignani to commence research and development of a GLP1 supplement for use in companion animals. Combini
TAMPA, Fla., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or “the Company”), a pet health and wellness company, today announced it has signed a research and development partnership with Aimia Pet Health to develop a GLP1 supplement for overweight pets under its Halo brand. More than half of all dogs and cats worldwide are classified as overweight or obese and can suffer from the same weight-related health complications as humans – including arthritis, dia